ReviewCurrent oncology (Toronto, Ont.)2025

Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium.

Catherine C Fahey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.